Publications | PubMed=19920829; DOI=10.1038/sj.bjc.6605448; PMCID=PMC2813756 Karim S. El-Sahwi, Stefania Bellone, Emiliano Cocco, Marilisa Cargnelutti, Francesca Casagrande, Marta Bellone, Maysa Abu-Khalaf, Natalia Buza, Fattaneh A. Tavassoli, Pei Hui, Dan-Arin Silasi ...Show all 16 authors... , Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Alessandro D. Santin; Show fewer authors In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. Br. J. Cancer 102:134-143(2010) PubMed=21246534; DOI=10.1002/cncr.25891; PMCID=PMC3128671 Joyce Varughese, Emiliano Cocco, Stefania Bellone, Maria de Leon, Marta Bellone, Paola Todeschini, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Alessandro D. Santin; Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody. Cancer 117:3163-3172(2011) PubMed=23891627; DOI=10.1016/j.ajog.2013.07.020 Diana P. English, Stefania Bellone, Emiliano Cocco, Ileana Bortolomai, Sergio Pecorelli, Salvatore Lopez, Dan-Arin Silasi, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Santin; Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2). Am. J. Obstet. Gynecol. 209:465.e1-465.e9(2013) PubMed=25268372; DOI=10.1038/bjc.2014.519; PMCID=PMC4453741 Carlton L. Schwab, Stefania Bellone, Diana P. English, Dana Marie Roque, S. Lopez, Emiliano Cocco, Roberta Nicoletti, Ileana Bortolomai, Elena Bonazzoli, Elena Ratner, Dan-Arin Silasi ...Show all 15 authors... , Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Santin; Show fewer authors Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo. Br. J. Cancer 111:1750-1756(2014) PubMed=26325104; DOI=10.1038/bjc.2015.306; PMCID=PMC4651122 Jonathan D. Black, Salvatore Lopez, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Carlton L. Schwab, Diana P. English, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner ...Show all 15 authors... , Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin; Show fewer authors PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas. Br. J. Cancer 113:1020-1026(2015) PubMed=26625219; DOI=10.1038/bjc.2015.388; PMCID=PMC4705897 Jonathan D. Black, Salvatore Lopez, Emiliano Cocco, Stefania Bellone, Gary Altwerger, Carlton L. Schwab, Diana P. English, Elena Bonazzoli, Federica Predolini, Francesca Ferrari, Elena Ratner ...Show all 15 authors... , Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin; Show fewer authors Erratum to: PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas. Br. J. Cancer 113:1641-1641(2015) PubMed=27894751; DOI=10.1016/j.ygyno.2016.11.023; PMCID=PMC5183545 Stefania Bellone, Eliana Bignotti, Silvia Lonardi, Francesca Ferrari, Floriana Centritto, Alice Masserdotti, Francesca Pettinella, Jonathan D. Black, Gulden Menderes, Gary Altwerger, Pei Hui ...Show all 29 authors... , Salvatore Lopez, Christopher de Haydu, Elena Bonazzoli, Federica Predolini, Luca Zammataro, Emiliano Cocco, Federico Ferrari, Antonella Ravaggi, Chiara Romani, Fabio Facchetti, Enrico Sartori, Franco Edoardo Odicino, Dan-Arin Silasi, Babak Litkouhi, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin; Show fewer authors Polymerase epsilon (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro. Gynecol. Oncol. 144:146-152(2017) |